Comparison of the Efficacy of Ticagrelor Combined With ASA to ASA Alone in Patients With Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

13,000

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

October 31, 2019

Conditions
Cerebrovascular AccidentCerebrovascular Accident, Acute
Interventions
DRUG

ticagrelor + ASA

On day 1, ticagrelor loading dose (2 tablets, ticagrelor 90mg) was given, followed by ticagrelor 90mg, twice daily Basic treatment: the first day received ASA loading dose, 300-325mg, and the server received ASA 75-100mg, once a day

DRUG

Placebo+ASA

Placebo loading dose on day 1 (2 tablets, matched with ticagrelor 90mg), followed by placebo twice daily (matched with ticagrelor 90mg) Basic treatment: the first day received ASA loading dose, 300-325mg, and the server received ASA 75-100mg, once a day

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Peking University Third Hospital

OTHER